- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05007314
Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
In this study, closely inspired by the paradigms of Berryessa, Coppola, and Salvato, perspectives on punishment based on psychobiological explanations of behaviour are assessed, aiming to understand how scientists with knowledge of human psychobiology versus lay people (of similar educational level) interpret offending behaviour. Human-science is contrasted to natural-science/arts graduates because the former have been exposed to and may possess scientific knowledge that shapes their understanding of behaviour, their views, and potential (essentialist) biases. In contrast, non-scientists have been found to possess scientific misconceptions that can impact their sentencing decisions. This leads to the question whether scientists may draw different judgements based on their professional knowledge and experience with psychological phenomena. If indeed scientists with greater insight on human behaviour are found to hold less punitive views on punishment and rehabilitation, that has important implications for criminal justice systems that rely on lay peoples' understanding of science.
One hundred sixty participants who completed all study procedures (2 main groups of 80 participants) will be surveyed. A sample size calculation was performed using G*Power version 3.1.9.4, based on Berryessa and colleagues who conducted a similar survey study in 2021 with comparable outcome measures and analyses. The required effect size is based upon approximately 3-4 outcome measures. The primary research question is between-groups, while secondary ones include within groups measures. Based on the power analysis, a sample of 160 participants will be targeted, which is enough for sufficient power for f = 0.25, power = 0.80, df = 4, for 2 different groups.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
South Holland
-
Leiden, South Holland, Países Bajos, 2333 AK
- Leiden University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Aged between 18 and 65
- Holding a university diploma or equivalent
Exclusion Criteria:
- Participants who did not complete the survey (appropriately) will be excluded
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Human Science
Arm 1 will include university graduates that hold at least a science undergraduate degree (or equivalent) in human science, including psychology, neuroscience, human biology, or medicine.
|
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
|
|
Comparador activo: Natural or non-science
Arm 2 will include university graduates from non-human or non-scientific fields such as engineering, history, language studies, or law.
|
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sentencing severity on 5-point questionnaire
Periodo de tiempo: Immediately after case presentation, an average of 1 minute.
|
This is the primary outcome measure of attitudes towards sentencing, measured via a questionnaire on a visual analogue scale from 1 (only treatment) to 5 (more than 5 years in prison)
|
Immediately after case presentation, an average of 1 minute.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 2021-07-16-D.S.V.-V2-3332
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- CÓDIGO_ANALÍTICO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .